Skip to main content
. 2020 Jun 23;1(3):100038. doi: 10.1016/j.xcrm.2020.100038

Table 1.

Comparison of Demographics and Treatment of WNT MB, Stratified by Relapse

No Relapse Relapse p Value
Age years (median + IQR) 10 (8–14.2) 11 (9.75–14.35) 0.45
Gender 0.09
Male 27 9
Female 50 6
M-status 0.65
M0 65 13
M+ 7 2
Extent of Resection 0.34
GTR 64 15
STR 8 0
Craniospinal Irradiation Dose 1
≤23.4 Gy 37 8
≥23.4 Gya 35 7
Chemotherapy 0.032
No chemotherapy or older protocols 18 6
CCNU-based 26 8
Cyclophosphamide/ifosfamide-based (>12 g/m2) 30 1
Chromosome 6 0.68
Balanced chromosome 6 10 1
Monosomy 6 66 14
Chromosome 17p 0.19
17p balanced 64 12
17p loss 6 3

GTR, gross total resection; STR, subtotal resection with residual >1.5 cm2. Cyclophosphamide/ifosfamide includes ICE regimens. CCNU-based includes treatment according to ACNS0331. Chromosomes 6 and 17 are arm-level losses. The p values are from a Fisher’s exact test, except age at diagnosis was determined using a Mann-Whitney U test. Bold p-values represent values below 0.05.

a

≥23.4-Gy craniospinal irradiation (CSI) includes 3 patients with 25-Gy CSI and 2 patients with 30.6-Gy CSI.